Voima Ventures

Voima Ventures is a venture capital firm based in Espoo, Finland, that focuses on seed, pre-seed, and early-stage investments in deep technology companies. Founded in 2019, the firm targets sectors such as bio and new materials, medical technologies, life sciences, imaging and optics, IoT and electronics, robotics, software, and artificial intelligence. Voima Ventures aims to support startups in the Nordic and Baltic regions, typically investing between €150,000 and €500,000, with the possibility of increasing investments in Series A and B rounds up to €2 million. The firm is dedicated to helping founders accelerate the growth of their ventures and bring innovative ideas to global markets.

René Kromhof

Venture Partner

Mikko Kumpulainen

Partner

Inka Mero

Co-Founder and Managing Partner

Kalle Ohman

Venture Partner

Jussi Sainiemi

Partner

Harry Santamäki

Venture Partner

Pontus Stråhlman

Partner

Past deals in Finland

Finnadvance

Seed Round in 2022
Finnadvance OY is a company based in Oulu, Finland, specializing in microtechnology and 3D biology solutions. Founded in 2018, it develops microfluidic organ-on-chips designed for pharmaceutical drug research and development. These innovative devices replicate the activities and physiological responses of entire organs, enabling more accurate studies in drug efficacy and safety. In addition to its core focus on organ-on-chips, Finnadvance also offers tailored hardware solutions and bio-materials for cell culture. Furthermore, the company provides aerial imaging and analysis services, catering to sectors such as forestry and agriculture, along with stockpile management.

StemSight

Seed Round in 2021
StemSight is a cell therapy startup developing novel treatments for blindness operating in Tampere, Finland.

Finnadvance

Seed Round in 2020
Finnadvance OY is a company based in Oulu, Finland, specializing in microtechnology and 3D biology solutions. Founded in 2018, it develops microfluidic organ-on-chips designed for pharmaceutical drug research and development. These innovative devices replicate the activities and physiological responses of entire organs, enabling more accurate studies in drug efficacy and safety. In addition to its core focus on organ-on-chips, Finnadvance also offers tailored hardware solutions and bio-materials for cell culture. Furthermore, the company provides aerial imaging and analysis services, catering to sectors such as forestry and agriculture, along with stockpile management.